DP036 | MOLECULAR MONITORING OF ROCK2 AND IGFBP6 AFTER CAR-T: THE IDENTIFICATION OF POSSIBLE MARKERS OF INFLAMMATION.
Introduction: CAR-T therapy has revolutionized the treatment of relapsed/refractory hematologic malignancies by enabling genetically modified T lymphocytes to target and eliminate tumor cells. However, it is often associated with severe toxicities, including cytokine release syndrome (CRS) and neur...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Ferrata Storti Foundation
2025-09-01
|
| Seri Bilgileri: | Haematologica |
| Online Erişim: | https://haematologica.org/article/view/12800 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|